Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells

Antiviral Therapy

Volumn 10, Issue 2, 2005, Pages 255-262

  Njai, Harr F ^a   Lewi, Paul J ^b   Janssen, Cornelus G M ^c   Garcia, Sergio ^a   Fransen, Katrien ^a   Kestens, Luc ^a   Vanham, Guido ^a   Janssen, Paul A J ^b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Centre for Molecular Design   (Belgium)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DAPIVIRINE; ETRAVIRINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; PHYTOHEMAGGLUTININ; POLYLYSINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG; VIRUS DNA; ZIDOVUDINE; PYRIDAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; TMC120 R147681; TMC120-R147681;

ARTICLE; CELL FREE SYSTEM; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOGRAPHIC ORIGIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PHENOTYPE; PRIORITY JOURNAL; PROVIRUS; SEXUAL TRANSMISSION; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS LATENCY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LEUKOCYTES, MONONUCLEAR; PYRIDAZINES; PYRIMIDINES; VIRUS REPLICATION;

EID: 22844446902     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. O'Farrel N. Enhanced efficiency of female-to-male HIV transmission in core groups in developing countries: the need to target men. Sexually Transmitted Diseases 2001; 28:84-91.
2. UNAIDS. UNAIDS 2004 report on the global AIDS epidemic - 4th global report. http://www.unaids.org/bangkok2004
3. De Clercq E. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. Antiviral Research 1998; 38:153-179.
4. Borkow G, Barnard J, Nguyen TM, Belmonte A, Wainberg MA & Parniak MA. Chemical barriers to HIV-1 infection: retrovirucidal activity of UC-781, a thiocarboxanilide non-nucleoside inhibitor of HIV-1 reverse transcriptase. Journal of Virology 1997; 71:3023-3030.
5. Balzarini J, Karlsson A, Perez-Perez MJ, Camarasa MJ & De Clercq E. Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of compound-resistant virus. Virology 1993; 196:576-585.
6. University of Pittsburgh Medical Centre. Grant Funds Research to Develop Microbicide Barrier to HIV. (2003). http://www.scienceblog.com
7. De Bethune MP, Andries K, Ludovici D, Lewi P, Azijn H, M de Jonge, Heeres J, Kukla M, Janssen P & Pauwels R. TMC-120 (R147681), a next generation NNRTI has potent in vitro activity against NNRTI-resistant HIV variants. 8th Conference on Retroviruses & Opportunistic Infections. 4-8 February 2001, Chicago, IL, USA. Abstract 304.
8. Das K, Clark AD, Buyer PL, Ludovici DW, de Bethune M-P, Andries K, Lewi P, Arnold E, Hughes SH, De Corte BL, Kavash RW, Kukla MJ, Pauwels R, de Jonge M, Daeyaert F, Koymans L, Vinkers M, Heeres J & Janssen PA. Could multiple modes of binding of a potent NNRTI TMC-125-R165335 explain its potency against common compound-resistant mutants? 10th Conference on Retroviruses & Opportunistic Infections. 10-14 February 2003, Boston, MA, USA. Poster number 613.
9. Lewi PJ, de Jonge M, Daeyaert F, Koymans L, Vinkers M, Heeres J, Janssen PA, Arnold E, Das K, Clark AD Jr, Hughes SH, Boyer PL, de Bethune MP, Pauwels R, Andries K, Kukla M, Ludovici D, De Corte B, Kavash R & Ho C. On the detection of multiple-binding modes of ligands to proteins, from biological, structural and modeling data. Journal of Computer-Aided Molecular Design 2003; 17:129-134.
10. Milman G & Sharman O. Mechnisms of HIV/SIV mucosal transmission. AIDS Research & Human Retroviruses 1994; 10:1305-1312.
11. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM & Ho DD. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. Journal of Experimental Medicine 1996; 183:215-225.
12. Masurier C, Salomon B, Guettari N, Pioche C, Lachapelle F, Guigon M & Klatzmann D. Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. Journal of Virology 1998; 72:7822-7829.
13. Zoeteweij JP & Blauvelt A. HIV dendritic cell interaction promote efficient viral infection of T cells. Journal of Biomedical Science 1998; 5:253-259.
14. Vanham G, Davis D, Willems B, Penne L, Kestens L, Janssens W & van der Groen G. Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones. AIDS 2000; 14:1874-1876.
15. Vanham G, Penne L, Allemeersch H, Kestens L, Willems B, van der Groen G, Jeang KT, Toossi Z & Rich E. Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS 2000; 14:2299-2311.
16. Van Herrewege Y, Penne L, Vereecken C, Fransen K, van der Groen G, Kestens L, Balzarini J & Vanham G. Activity of reverse-transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for post-exposure prophylaxis of sexual HIV transmission. AIDS Research & Human Retroviruses 2002; 18:1091-1102.
17. Kawamura T, Cohen SS, Borris DL, Aquilino EA, Glushakova S, Margolis LB, Orenstein JM, Offord RE, Neurath AR & Blauvelt A. Candidate microbicides block HIV-1 infection of human immature langerhans cells within epithelial tissue explants. Journal of Experimental Medicine 2000; 192:1491-1500.
18. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM & Schuler G. Proliferating dendritic cell progenitors in human blood. Journal of Experimental Medicine 1994; 180:83-93.
19. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG & van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587-597.
20. Sallusto F & Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor alpha. Journal of Experimental Medicine 1994; 179:1109-1118.
21. Reed LJ & Muench H. A simple method of estimating fifty percent endpoints. American Journal of Hygiene 1938; 27:493-497.
22. Peden KWC, Martin MA & Karn J. Virological and molecular genetic techniques for studies of established HIV isolates. In A Practical Approach to HIV Virology & Immunology, 1995; pp. 21-45. Edited by J Karn. New York: Oxford University Press.
23. Beirnaert E, Willmes B, Peeters M, Bouckaert A, Heyndrickx L, Zhong P, Vereecken K, Coppens S, Davis D, Ndumbe P, Janssens W & van der Groen G. Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. Journal of Virological Methods 1998; 73:65-70.
24. Zijenah LS, Humphrey J, Nathoo K, Malaba L, Zvandasara P, Mahomva A, Iliff P & Mbizvo MT. Evaluation of the prototype Roche DNA amplification kit incorporating the new SSK145 and SKCC1B primers in detection of the human immunodeficiency virus type 1 DNA in Zimbabwe. Journal of Clinical Microbiology 1999; 27:3569-3571.
25. Harman S, Watts P, Shattock R, Griffin G & Van Roey J. TMC-120 block HIV infection in cellular and human cervical tissue models. Microbicides. 28-31 March 2004, London, UK. Abstract 02591.